Sparavigna, Amelia Carolina
2020-06-29
<p>Discussion of scholar papers published until June 29, 2020, on Ivermectin, and of news that we can find about its use for Covid-19. A list of clinical trials is also given. For what concerns scholar papers, we report among them a preprint posted on 10 June in MedRχiv, which concludes that Ivermectin was associated with lower mortality during treatment of Covid-19. From news, we consider in particular the case of Iquitos, capital city of the Loreto Region in Peru, where, by May 25, Covid-19 cases and deaths had dropped notably. The formulation of ivermectin used in Peru is also discussed, in particular that of the oral solution disclosed by the Peruvian Government.</p>
Before reading this work, please consider that I am not a physician. I do not suggest the use of ivermectin. I am not touting this drug. This analysis of publications and news about ivermectin is made in the framework of a wider investigation about information concerning drugs used for Covid-19.
https://doi.org/10.5281/zenodo.3922298
oai:zenodo.org:3922298
eng
Zenodo
https://zenodo.org/communities/covid-19
https://doi.org/10.5281/zenodo.3893750
info:eu-repo/semantics/openAccess
Creative Commons Attribution 4.0 International
https://creativecommons.org/licenses/by/4.0/legalcode
Covid-19
Ivermectin
Hydroxychloroquine
Doxycycline
Ivermectin for Covid-19
info:eu-repo/semantics/workingPaper